XLV261023C00172000
XLV Oct 23 2026 172.00 Call
optionOPRA
EODOct 21, 2026
6.36USD+61.013%(+2.41)1Vol126OI
Loading…
Underlying
Underlying Price
$181.74
Type
Call
Strike
172
Expiration
Oct 23, 2026
DTE
0d
Moneyness
ITM
Intrinsic
$9.74
XLV 172 Call Across Expirations
| Expiration | DTE | Last | Change | Vol | Open Int |
|---|---|---|---|---|---|
| Oct 23, 2026 | 0d | $6.36 | +61.01% | 1 | 126 |
| Oct 30, 2026 | 7d | $5.67 | -6.59% | 1 | 40 |
| Nov 6, 2026 | 14d | $8.16 | +220.00% | 5 | 27 |
| Nov 13, 2026 | 21d | $6.08 | +29.36% | 6 | 107 |
| Nov 20, 2026 | 28d | $9.60 | +31.51% | 6 | 218 |
| Nov 27, 2026 | 35d | $6.72 | -33.47% | 20 | 12 |
| Mar 19, 2027 | 147d | $13.46 | +30.68% | 1 | 39 |
| Jun 17, 2027 | 237d | — | — | 0 | 0 |
| Jan 19, 2029 | 819d | $21.39 | +0.00% | 4 | 4 |
XLV Nearby Strikes · Oct 23, 2026
| Strike | Last | Change | Vol | Open Int | Moneyness |
|---|---|---|---|---|---|
| 167 C | $11.73 | -7.42% | 1 | 88 | ITM |
| 167.5 C | $10.84 | +32.52% | 1 | 7 | ITM |
| 168 C | $10.43 | +2.25% | 1 | 82 | ITM |
| 169 C | $8.85 | +13.03% | 1 | 114 | ITM |
| 170 C | $8.50 | -12.01% | 1 | 202 | ITM |
| 171 C | $5.60 | -4.27% | 2 | 85 | ITM |
| 172 C | $6.36 | +61.01% | 1 | 126 | ITM |
| 172.5 C | $6.10 | -12.23% | 15 | 147 | ITM |
| 173 C | $5.38 | +46.99% | 16 | 133 | ITM |
| 174 C | $5.93 | +141.06% | 201 | 139 | ITM |
| 175 C | $4.24 | -9.79% | 5 | 96 | ITM |
| 176 C | $3.07 | -27.25% | 1 | 33 | ITM |
| 177 C | $2.57 | -14.33% | 4 | 87 | ITM |
XLV Profile
The investment seeks investment results that, before expenses, correspond generally to the price and yield performance of publicly traded equity securities of companies in the Health Care Select Sector Index. In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.